The congestive heart failure drugs market is anticipated to grow at a significant CAGR of 16.1% during the forecast period (2022-2028). Some of the congestive heart failure drugs such as angiotensin-converting enzyme inhibitors are given in a state of congestive heart failure. This works by relaxing the blood vessels of the heart. Some angiotensin-converting enzyme inhibitors are ramipril, enalapril, and lisinopril. Angiotensin-2 receptor blockers are also used to relax blood vessels of the heart and some of them are valsartan and candesartan. An increase in the number of heart failure patients is the major factor that has surged the demand for such drugs and the heart failure prevalence is expected to drive the market during the forecast period. For instance, in June 2020,as per an article published in the AME Medical Journal, there were around 64.34 million cases of Heart Failure in the world.
A full report of Global Congestive Heart Failure Drugs Market is available at:https://orionmarketreports.com/global-congestive-heart-failure-drugs-market/109560/
Some major players operating in the congestive heart failure drugs market include Amgen Inc, Glaxo SmithKline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2020, Food and Drug Administration has approved the Farxiga drug which is useful in the treatment of congestive heart failure. This drug is manufactured by AstraZeneca Pharmaceuticals LP. This drug has been found effective in reducing the ejection fraction and decreasing the risk of hospitalization and death in case of heart failure. This drug belongs to a class of sodium-glucose co-transporter 2 inhibitors.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Drug Type
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Amgen Inc, Glaxo Smith Kline Plc, Pfizer Inc, Teva Pharmaceutical Industries Ltd.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Congestive Heart Failure Drugs MarketReport by Segment
By Drug Type
- ACE Inhibitors
- Angiotensin 2 Receptor Blockers
- Beta Blockers
- Mineral corticoid Receptor Antagonists
- Diuretics
- Ivabradine
- Sacubritil Valsartan
- Hydralazine With Nitrate
- Digoxin
By End-User
- Hospital
- Clinic
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
